Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NRTI-Sparing Regimen in HIV
NCT00143689Phase 4Completed
- Sponsor
- University of British Columbia
- Start
- Apr 2002
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lopinavir + ritonavir and nevirapine in human immunodeficiency virus infection (HIV) (3 arms), sponsored by University of British Columbia. Primary endpoint: Changes in mitochondrial DNA/Nuclear DNA ratio at 48 weeks. Started Apr 2002; status: completed.
02
Drugs
lopinavir + ritonavirnevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00143689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00143689.